Literature DB >> 21640112

Inflammation promotes the loss of adeno-associated virus-mediated transgene expression in mouse liver.

Ekaterina Breous1, Suryanarayan Somanathan, Peter Bell, James M Wilson.   

Abstract

BACKGROUND & AIMS: Non-self transgenes delivered to mouse liver via adeno-associated virus (AAV) are expressed stably due to the induction of immune tolerance. However, such transgene expression has been reported to be lost in higher-order primates. We investigated whether inflammatory processes, which likely differ between species, impact the stability of transgene expression.
METHODS: We developed a mouse model that mimics a scenario in which a subject that has received hepatic AAV-mediated gene transfer develops subsequent, vector-unrelated, systemic inflammation.
RESULTS: Inflammation eliminated previously stable expression of transgenes delivered by AAV; the limited tissue destruction and persistence of AAV genomes implicated pathways besides the cytotoxic T-cell response. Tumor necrosis factor-a down-regulated expression of the transgene from the AAV, indicating a role for similar inflammatory cytokines in such loss of transgene expression.
CONCLUSIONS: Inflammation can block AAV-mediated expression of transgenes in mouse liver. The presence of inflammation might therefore affect hepatic expression of transgenes from viral vectors in humans.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640112      PMCID: PMC3269906          DOI: 10.1053/j.gastro.2011.04.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

Authors:  I Hoerr; R Obst; H G Rammensee; G Jung
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

2.  TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.

Authors:  R S Sung; L Qin; J S Bromberg
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

3.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

Review 4.  Innate immune sensing and its roots: the story of endotoxin.

Authors:  Bruce Beutler; Ernst Th Rietschel
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

5.  Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

Authors:  Qing Zhu; Colt Egelston; Susan Gagnon; Yongjun Sui; Igor M Belyakov; Dennis M Klinman; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

Review 6.  Noncytolytic control of viral infections by the innate and adaptive immune response.

Authors:  L G Guidotti; F V Chisari
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

7.  Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.

Authors:  N Tao; G P Gao; M Parr; J Johnston; T Baradet; J M Wilson; J Barsoum; S E Fawell
Journal:  Mol Ther       Date:  2001-01       Impact factor: 11.454

8.  Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ.

Authors:  H P Fischer; M E Ortiz-Pallardó; Y Ko; C Esch; H Zhou
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

9.  Circulating mononuclear cells nuclear factor-kappa B activity, plasma xanthine oxidase, and low grade inflammatory markers in adult patients with familial hypercholesterolaemia.

Authors:  J T Real; S Martínez-Hervás; A B García-García; M Civera; F V Pallardó; J F Ascaso; J R Viña; F J Chaves; R Carmena
Journal:  Eur J Clin Invest       Date:  2009-12-11       Impact factor: 4.686

Review 10.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics.

Authors:  M A Kay; J C Glorioso; L Naldini
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

View more
  17 in total

1.  Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.

Authors:  Carole E Harbison; Wendy S Weichert; Brittney L Gurda; John A Chiorini; Mavis Agbandje-McKenna; Colin R Parrish
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.

Authors:  Suryanarayan Somanathan; Frank Jacobs; Qiang Wang; Alexandra L Hanlon; James M Wilson; Daniel J Rader
Journal:  Circ Res       Date:  2014-07-14       Impact factor: 17.367

3.  TLR9 signaling mediates adaptive immunity following systemic AAV gene therapy.

Authors:  Scott N Ashley; Suryanarayan Somanathan; April R Giles; James M Wilson
Journal:  Cell Immunol       Date:  2019-10-26       Impact factor: 4.868

4.  Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.

Authors:  Ashley T Martino; Etiena Basner-Tschakarjan; David M Markusic; Jonathan D Finn; Christian Hinderer; Shangzhen Zhou; David A Ostrov; Arun Srivastava; Hildegund C J Ertl; Cox Terhorst; Katherine A High; Federico Mingozzi; Roland W Herzog
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

5.  In vivo evaluation of adeno-associated virus gene transfer in airways of mice with acute or chronic respiratory infection.

Authors:  Melissa Myint; Maria P Limberis; Peter Bell; Suryanarayan Somanathan; Angela Haczku; James M Wilson; Scott L Diamond
Journal:  Hum Gene Ther       Date:  2014-09-22       Impact factor: 5.695

6.  Structure of the AAVhu.37 capsid by cryoelectron microscopy.

Authors:  Jason T Kaelber; Samantha A Yost; Keith A Webber; Emre Firlar; Ye Liu; Olivier Danos; Andrew C Mercer
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-02-03       Impact factor: 1.056

7.  Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice.

Authors:  Eva Billerbeck; Joshua A Horwitz; Rachael N Labitt; Bridget M Donovan; Kevin Vega; William C Budell; Gloria C Koo; Charles M Rice; Alexander Ploss
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

8.  The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.

Authors:  Christina Raupp; Matthias Naumer; Oliver J Müller; Brittney L Gurda; Mavis Agbandje-McKenna; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

9.  Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy.

Authors:  Yi Gong; Anna Berenson; Fiza Laheji; Guangping Gao; Dan Wang; Carrie Ng; Adrienn Volak; Rene Kok; Vasileios Kreouzis; Inge M Dijkstra; Stephan Kemp; Casey A Maguire; Florian Eichler
Journal:  Hum Gene Ther       Date:  2018-12-18       Impact factor: 5.695

10.  Extracorporeal delivery of rAAV with metabolic exchange and oxygenation.

Authors:  Scott Bieber; Jeffrey B Halldorson; Eric Finn; Suhail Ahmad; Jeffrey S Chamberlain; Guy L Odom
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.